Pseudomonas aeruginosa

Pseudomonas aeruginosa

Challenging the Paradigm: Non-Canonical Exoprotease Cheating in Clinical Pseudomonas aeruginosa Isolates

Researchers at the Metropolitan Autonomous University in Mexico City have uncovered new insights into the behavior of Pseudomonas aeruginosa, a Gram-negative bacteria commonly associated with cystic fibrosis and other infections. According to their study, published in FEMS Microbiology Ecology, some clinical isolates of P. aeruginosa have evolved unique mechanisms to

Pseudomonas aeruginosa

Challenging the Paradigm: Non-Canonical Exoprotease Cheating in Clinical Pseudomonas aeruginosa Isolates

Researchers at the Metropolitan Autonomous University in Mexico City have uncovered new insights into the behavior of Pseudomonas aeruginosa, a Gram-negative bacteria commonly associated with cystic fibrosis and other infections. According to their study, published in FEMS Microbiology Ecology, some clinical isolates of P. aeruginosa have evolved unique mechanisms to

Pseudomonas aeruginosa

New Research Reveals Limitations of Xeruborbactam in Treating Pseudomonas Aeruginosa

Researchers from the Vietnamese-German Centre for Medical Research have conducted a study evaluating the effectiveness of cefiderocol in combination with either taniborbactam or xeruborbactam against cefiderocol-resistant Pseudomonas aeruginosa isolates from Vietnam and Nigeria. The study found that taniborbactam restored cefiderocol susceptibility in 20 out of 21 isolates (95.2%), while

Pseudomonas aeruginosa

Investigation of Antibacterial Activity of Rhamnus Cathartica L. and Its Anti-qs Potential on Pseudomonas Aeruginosa Pao1

Research conducted at Suleyman Demirel University in Isparta, Turkiye, has discovered that the R. cathartica L. seed extract exhibits antimicrobial activity against both Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa. The study found that the extract's inhibitory effect on P. aeruginosa PAO1 was moderately significant, with a notable